Aspirin slows DNA mutations in pre-cancerous conditions

The following is an excerpt.

Researchers analyzed biopsy samples from 13 patients with a pre-cancerous condition known as Barrett’s esophagus, who were tracked for six to 19 years. The goal of the analysis was to track the rate of mutations in tissues sampled at different times. They performed a crossover study in which some patients started taking daily aspirin for several years and then stopped, while others started taking aspirin for the first time during observation.

The team found that biopsies taken while patients were on an aspirin had accumulated new mutations about ten times slower than biopsies obtained during years when patients were not taking aspirin.

Read the full story here: Aspirin Slows DNA Mutations In Pre-Cancerous Conditions

Outbreak
Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
Infographic: What are mRNA COVID-19 vaccines and how do they work?

Infographic: What are mRNA COVID-19 vaccines and how do they work?

As of 1 December 2020, thirteen vaccines have reached the final stage of testing: where they are being given to ...
favicon

Environmental Working Group: EWG challenges safety of GMOs, food pesticide residues

Known by some as the "Environmental Worrying Group," EWG lobbies ...
m hansen

Michael Hansen: Architect of Consumers Union ongoing anti-GMO campaign

Michael K. Hansen (born 1956) is thought by critics to be ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend